HUGE JAN. 2015 PR NIT FDA APPROVED >>> Palm Beach Gardens, Florida – January 01, 2015 –
NIT Enterprises, Inc. (NITE) has completed successful testing of its patented lightweight ionizing X-Ray and Gamma Ray absorbing technology utilizing nano-strands of DNA and RNA with their associated nucleotides.
The ability to shield industrial materials without using heavy metals allows this technology to be applied in a myriad of applications where shielding is not possible for reasons of weight and size of currently existing methods. Application of NIT's shielding technologies provides a unique tool for new and existing product enhancements in healthcare, defense, space and industrial environments.
Nucleotides are approved by the FDA for injection into the human body. NIT is in preliminary discussions with a Department of Defense agency regarding testing the technology for injection for military and first responder applications. Governmental agencies have significant budget dollars set aside for applications which include radiation shielding for structures, vehicles, electronics and aerospace applications.
NIT's demonstration utilizes the unique bonding sites located on the sides of the DNA/RNA ladder where its patented process is used to bond heavy metal nano-particals creating a nano-sized wide spectrum radiation absorber. NIT has developed extensive positive data on its nucleotide micro-structures.
NIT's successful Gamma Ray tests were conducted at Borg Performance Coatings, LLC of Daytona Beach, Florida by their well-known chemist and chemical engineer, Mr. Bo Gimvang. The X-Ray tests were performed by Mr. Michael Latimer, M.S.R.S., RT(R) Clinical Coordinator Medical Imaging, an Assistant Professor at Palm Beach State College department of Radiography.
Gary Smith, CEO, of NIT stated "This discovery ranks as one of the most profound and valuable discoveries for almost limitless technological enhancement in industrial, medical and the chemical development. The potential revenues to be generated by commercialization of these exclusive technologies can be exploited through manufacturing and licensing production for disruptive applications which are also expected to generate significantly more intellectual property enhancements".
NIT Enterprises, Inc. (d/b/a Nucleotide Industrial Technologies) (NITE) was created to improve public safety and to provide a new measure of protection for commercial, industrial, and personal products that enhance the longevity of living and non-living substances based upon unique proprietary NA technologies developed by our award winning scientist and technology team. This new technology is the infusion of ingredients, known as nucleotides, into a multiplicity of common products enhanced by their presence. The Nucleotides were derived by atomic level research that demonstrates their ability to provide Ultraviolet (UV) rays screening capability at the molecular level
News 
Market Data 
Discover 
AI
